Geode Capital Management, LLC Provention Bio, Inc. Transaction History

Geode Capital Management, LLC

$1.12 Trillion
Q2 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$6.7 - $24.21 $767,150 - $2.77 Million	114,500 Added 8.66%	1,436,689 $34.6 Million
Q4 2022 Feb 13, 2023	BUY	$4.52 - $10.57 $566,771 - $1.33 Million	125,392 Added 10.48%	1,322,189 $14 Million
Q3 2022 Nov 14, 2022	BUY	$3.43 - $5.62 $828,509 - $1.36 Million	241,548 Added 25.29%	1,196,797 $5.39 Million
Q2 2022 Aug 12, 2022	SELL	$3.65 - $7.3 $41,942 - $83,884	-11,491 Reduced 1.19%	955,249 $3.82 Million
Q1 2022 May 13, 2022	BUY	$3.4 - $7.88 $38,780 - $89,879	11,406 Added 1.19%	966,740 $7.08 Million
Q4 2021 Feb 11, 2022	SELL	$5.59 - $7.39 $473,875 - $626,465	-84,772 Reduced 8.15%	955,334 $5.37 Million
Q3 2021 Nov 12, 2021	BUY	$5.66 - $8.33 $563,181 - $828,851	99,502 Added 10.58%	1,040,106 $6.66 Million
Q2 2021 Aug 13, 2021	BUY	$6.71 - $11.04 $502,270 - $826,388	74,854 Added 8.65%	940,604 $7.93 Million
Q1 2021 May 12, 2021	BUY	$10.12 - $19.45 $1.54 Million - $2.96 Million	152,127 Added 21.32%	865,750 $9.09 Million
Q4 2020 Feb 12, 2021	BUY	$11.79 - $18.94 $847,618 - $1.36 Million	71,893 Added 11.2%	713,623 $12.1 Million
Q3 2020 Nov 13, 2020	BUY	$10.34 - $15.2 $905,484 - $1.33 Million	87,571 Added 15.8%	641,730 $8.23 Million
Q2 2020 Aug 13, 2020	BUY	$7.81 - $17.0 $2.06 Million - $4.48 Million	263,306 Added 90.53%	554,159 $7.82 Million
Q1 2020 May 14, 2020	BUY	$5.42 - $17.75 $198,740 - $650,857	36,668 Added 14.43%	290,853 $2.68 Million
Q4 2019 Feb 13, 2020	SELL	$5.84 - $14.9 $69,998 - $178,591	-11,986 Reduced 4.5%	254,185 $3.79 Million
Q3 2019 Nov 12, 2019	BUY	$6.83 - $13.0 $658,473 - $1.25 Million	96,409 Added 56.79%	266,171 $1.82 Million
Q2 2019 Aug 14, 2019	BUY	$2.3 - $13.79 $390,452 - $2.34 Million	169,762 New	169,762 $2.05 Million

Others Institutions Holding PRVB

# of Institutions

Shares Held

170K

Call Options Held

Put Options Held

Odey Asset Management Group LTD London, X0

170K
Shares

$0
1.36% of portfolio

View Full List

About Provention Bio, Inc.

Ticker PRVB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 81,549,904
Description
Provention Bio, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics and solutions to intercept and prevent immune-mediated diseases. Its products candidates include PRV-031 teplizumab and monoclonal antibodies (mAb) that is in Phase III clinical trial for the interception of type one...

More about PRVB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account